21.06.2013 Views

Ganong's Review of Medical Physiology, 23rd Edition

Ganong's Review of Medical Physiology, 23rd Edition

Ganong's Review of Medical Physiology, 23rd Edition

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

58 SECTION I Cellular & Molecular Basis <strong>of</strong> <strong>Medical</strong> <strong>Physiology</strong><br />

Growth factor<br />

Receptor<br />

Inactive<br />

Ras<br />

T<br />

GDP GTP<br />

K Grb2 SOS<br />

Nucleus<br />

FIGURE 2–30 One <strong>of</strong> the direct pathways by which growth<br />

factors alter gene activity. TK, tyrosine kinase domain; Grb2, Ras activator<br />

controller; Sos, Ras activator; Ras, product <strong>of</strong> the ras gene; MAP K,<br />

mitogen-activated protein kinase; MAP KK, MAP kinase kinase; TF,<br />

transcription factors. There is cross-talk between this pathway and the<br />

cAMP pathway, as well as cross-talk with the IP 3–DAG pathway.<br />

some have little or no cytoplasmic tail. However, they initiate<br />

tyrosine kinase activity in the cytoplasm. In particular, they<br />

activate the so-called Janus tyrosine kinases (JAKs) in the<br />

cytoplasm (Figure 2–31). These in turn phosphorylate STAT<br />

proteins. The phosphorylated STATs form homo- and heterodimers<br />

and move to the nucleus, where they act as transcription<br />

factors. There are four known mammalian JAKs and<br />

seven known STATs. Interestingly, the JAK–STAT pathway can<br />

also be activated by growth hormone and is another important<br />

direct path from the cell surface to the nucleus. However, it<br />

should be emphasized that both the Ras and the JAK–STAT<br />

pathways are complex and there is cross-talk between them and<br />

other signaling pathways discussed previously.<br />

Finally, note that the whole subject <strong>of</strong> second messengers<br />

and intracellular signaling has become immensely complex,<br />

with multiple pathways and interactions. It is only possible in<br />

a book such as this to list highlights and present general<br />

themes that will aid the reader in understanding the rest <strong>of</strong><br />

physiology (see Clinical Box 2–3).<br />

HOMEOSTASIS<br />

Ras Ras<br />

Cell membrane<br />

Active<br />

Ras<br />

MAP K<br />

TF<br />

MAP KK<br />

Altered gene activity<br />

The actual environment <strong>of</strong> the cells <strong>of</strong> the body is the interstitial<br />

component <strong>of</strong> the ECF. Because normal cell function<br />

Raf<br />

ISF<br />

A<br />

Cytoplasm<br />

B<br />

C<br />

D<br />

JAK<br />

STAT<br />

STAT<br />

JAK<br />

JAK<br />

Ligand<br />

P<br />

P P<br />

STAT<br />

P P<br />

STAT<br />

JAK<br />

P<br />

Ligand<br />

Ligand<br />

P<br />

FIGURE 2–31 Signal transduction via the JAK–STAT<br />

pathway. A) Ligand binding leads to dimerization <strong>of</strong> receptor. B) Activation<br />

and tyrosine phosphorylation <strong>of</strong> JAKs. C) JAKs phosphorylate<br />

STATs. D) STATs dimerize and move to nucleus, where they bind to response<br />

elements on DNA. (Modified from Takeda K, Kishimoto T, Akira S: STAT6:<br />

Its role in interleukin 4-mediated biological functions. J Mol Med 1997;75:317.)<br />

JAK<br />

P<br />

Ligand<br />

P<br />

JAK<br />

JAK<br />

STAT<br />

P<br />

P P<br />

P<br />

P<br />

STAT<br />

DNA<br />

P<br />

P<br />

JAK<br />

STAT<br />

STAT<br />

Nucleus<br />

Receptor

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!